Protein folding

Proteostasis Therapeutics to Present at the Cantor Global Healthcare Conference

Retrieved on: 
Thursday, September 27, 2018
Biology, Biotechnology, Nature, Protein folding, Homeostasis, Proteomics, Proteostasis, Biopharmaceutical, Cystic fibrosis, Forward-looking statement

A live audio webcast of theCantor Global Healthcare Conference presentation will be available on the Investor Events page in the Investors & Media section of the Company's website, www.proteostasis.com .

Key Points: 
  • A live audio webcast of theCantor Global Healthcare Conference presentation will be available on the Investor Events page in the Investors & Media section of the Company's website, www.proteostasis.com .
  • A replay of the webcast will be available on the Company's website following the presentation.
  • Proteostasis Therapeutics, Inc.is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis and other diseases caused by dysfunctional protein processing.
  • We assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Proteostasis Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

Retrieved on: 
Thursday, May 31, 2018
Biology, Biotechnology, Protein folding, Nature, Homeostasis, Proteomics, Proteostasis, Cystic fibrosis, Biopharmaceutical

BOSTON, May 31, 2018 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced that Po-Shun Lee, M.D., the Company's Chief Medical Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 2:30 p.m.

Key Points: 
  • BOSTON, May 31, 2018 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced that Po-Shun Lee, M.D., the Company's Chief Medical Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 2:30 p.m.
  • A live audio webcast of theJefferies 2018 Global Healthcare Conference presentation will be available on the Investor Events page in the Investors & Media section of the Company's website, www.proteostasis.com .
  • Proteostasis Therapeutics, Inc.is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis and other diseases caused by dysfunctional protein processing.
  • We assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.